Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
M
Müller, Dieter J.
Bethesda Spital AG, Basel, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Dieter J. Müller
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Dieter J. Müller
MacDonald, Mia
University of North Carolina
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Mia MacDonald
Mackiewicz, Jacek
Poznan University of Medical Sciences, Poznan, Poland
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Jacek Mackiewicz
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Jacek Mackiewicz
Madajewski, Brian
OncoNano Medicine
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Brian Madajewski
Maduekwe, Ugwuji
Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Ugwuji Maduekwe
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Ugwuji Maduekwe
Madzo, Jozef
Coriell Institute for Medical Research
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Jozef Madzo
Magbanua, Mark Jesus
University of California San Francisco
The Use of ctDNA in the Management of Breast Malignancies: Current use and Future Directions
Location:Ballroom A
Mark Jesus Magbanua
Magge, Deepa
Vanderbilt University Medical Center
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Deepa Magge
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Deepa Magge
Tumor Board/Case Presentations
Location:SSO HUB Theater
Deepa Magge
Mahadevan-Jansen, Anita
Vanderbilt University
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Anita Mahadevan-Jansen
Mahajan, Deepti
Downstate School of Medicine
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Deepti Mahajan
Mahar, Alyson
Queens University
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Alyson Mahar
Maher, Christopher
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Christopher Maher
Maithel, Shishir
Emory
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Shishir Maithel
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Shishir Maithel
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Shishir Maithel
HPB Great Debate: Neoadjuvant Therapy Should be Routinely Given for High-risk Intrahepatic Cholangiocarcinoma
Location:Ballroom A
Shishir Maithel
Ma, Jiawen
Melanoma Institute Australia
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Jiawen Ma
Maker, Ajay
University of California, San Francisco
25: Combination Immunotherapy with Oncolytic Virus Induces Immunogenic Cell Death and T-cell Proliferation in Colon Cancer
Location:Ballroom C
Ajay Maker
Maki, Harufumi
MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Harufumi Maki
Malik, Manmeet
New York-Presbyterian Queens
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Manmeet Malik
Malinowski, Catalina
MD Anderson Cancer Center
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer
Location:Veterans Memorial Auditorium
Catalina Malinowski
Mallory, Melissa
Moffitt Cancer Center
Breast Poster Presentations 3
Location:SSO HUB: Breast & Endocrine Zone
Melissa Mallory
Mallow, Crystal
Vaccinex, Inc.
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Crystal Mallow
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Crystal Mallow
Maluccio, Mary
LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Mary Maluccio
Mammen, Joshua
University of Nebraska
De-escalation of Surgery for Melanoma
Location:Ballroom C
Joshua Mammen
Mamtani, Anita
Memorial Sloan Kettering Cancer Center
P1: Axillary dissection is avoidable in the majority of cT1N0 triple negative and HER2+ breast cancers having upfront surgery with adjuvant radiation
Location:SSO HUB: Breast & Endocrine Zone
Anita Mamtani
Mangieri, Chris
Tripler Army Medical Center
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Chris Mangieri
Mansfield, Paul
The University of Texas MD Anderson Cancer Center
100: Robotic Subtotal Gastrectomy with D2 Lymph Node Dissection using Indocyanine Green Sentinel Lymphatic Mapping
Location:Veterans Memorial Auditorium
Paul Mansfield
Mantha, Rohit
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Rohit Mantha
Marchetti, Michael
Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
P42: Clinical Benefit of Sentinel Lymph Node Biopsy Nomograms for Head and Neck Melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Michael Marchetti
Marin, Chelsea
University of Rochester Medical Center
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Chelsea Marin
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Chelsea Marin
Markellou, Pagona
Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Pagona Markellou
Maroun, Justin
Mayo Clinic
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Justin Maroun
Marsh, Megan
University of Colorado School of Medicine, Department of Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Megan Marsh
Martin, Bradley
University of Arkansas for Medical Sciences
83: Adherence to and outcomes of extended venous thromboembolism prophylaxis after complex gastrointestinal cancer surgery
Location:Veterans Memorial Auditorium
Bradley Martin
Martinez-Said, Hector
Instituto Nacional de Cancerologia
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Hector Martinez-Said
Martinie, John
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
John Martinie
Martin, Robert
University of Louisville School of Medicine, Department of Surgery
88: Optimal Radiation Dose Intensity: Low- vs. High-Dose in the Neo-Adjuvant Treatment of Locally Advanced Esophageal Cancer
Location:Ballroom B
Robert Martin
Masoud, Sabran
Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Sabran Masoud
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sabran Masoud
Massey, Andrew
NIBIB/IRP
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Andrew Massey
Mateo, Alina
Pennsylvania Hospital
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Alina Mateo
Mathes, David
Department of Surgery, University of Colorado Anschutz Medical Campus
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
David Mathes
Matrai, Zoltan
Hamad Medical Corporation, General Surgery, Doha, Qatar
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Zoltan Matrai
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Zoltan Matrai
Matsukuma, Karen
Department of Pathology and Laboratory Medicine, UC Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Karen Matsukuma
Matsuzaki, Junko
University of Chicago Medicine Comprehensive Cancer Center
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Junko Matsuzaki
Mattison, Yvette
LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Yvette Mattison
Mavros, Michail
University of Arkansas for Medical Sciences
83: Adherence to and outcomes of extended venous thromboembolism prophylaxis after complex gastrointestinal cancer surgery
Location:Veterans Memorial Auditorium
Michail Mavros
Ma, Xiaofen
Guangdong Second Provincial General Hospital. Guangzhou, China
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)
Location:Ballroom A
Xiaofen Ma
Maxwell, Conor
Allegheny Health Network
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Conor Maxwell
Maxwell, Jess
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Jess Maxwell
HPB Parallel Session 2
Location:Ballroom A
Jess Maxwell
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jess Maxwell
Mayer, Erica
Dana-Farber Cancer Institute
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Erica Mayer
Mayerson, Joel
The James Cancer Hospital and Solove Research Institute
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Joel Mayerson
McAuliffe, John
Montefiore Medical Center/ Albert Einstein College of Medicine
P14: ART1, a mono-ADP-ribosyl transferase, is increased by chemotherapy and radiotherapy and is a novel target in colorectal carcinoma.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
John McAuliffe
McCall, Linda
Alliance Statistics and Data Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Linda McCall
McCarter, Martin
University of Colorado School of Medicine
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Martin McCarter
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Martin McCarter
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Martin McCarter
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Martin McCarter
McCarthy, Anne
Cancer Programs, American College of Surgeons, Chicago, IL
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Anne McCarthy
McCormick, Moira
NIBIB/IRP
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Moira McCormick
McDonald, Gabriela
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Gabriela McDonald
McDonald, Hannah
Department of Surgery, University of Kentucky College of Medicine
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Hannah McDonald
McGinnis, Reliza
University of Michigan
P46: Histotripsy ablation abrogates tumor hypoxia and induces immunogenic cancer cell death
Location:SSO HUB: Melanoma & Sarcoma Zone
Reliza McGinnis
McGue, Jake
University of Michigan
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing
Location:Ballroom B
Jake McGue
McGuire, Kandace
Virginia Commonwealth University
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Kandace McGuire
Mcintyre, Caitlin
Memorial Sloan Kettering Cancer Center
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Caitlin Mcintyre
McIntyre, Sarah
New York University
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Sarah McIntyre
McIssac, Daniel
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Daniel McIssac
McKenzie, Travis
Endocrine and Metabolic Surgery, Department of Surgery, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Travis McKenzie
McKillop, Iain
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Iain McKillop
McKinley, Sophia
Memorial Sloan Kettering Cancer Center
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Sophia McKinley
Medina, Theresa
University of Colorado Cancer Center – Anschutz Medical Campus, Aurora, CO, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Theresa Medina
Medin, Caroline
Emory University
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Caroline Medin
Meguid, Robert
University of Colorado School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Robert Meguid
Mehlen, Patric
Université Claude Bernard Lyon
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer
Location:Ballroom A
Patric Mehlen
Mehrara, Babak
Memorial Sloan Kettering Cancer Center
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Babak Mehrara
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Babak Mehrara
Mehra, Siddharth
1University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Siddharth Mehra
Mehta, Rutika
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Rutika Mehta
melanie, lyden
Endocrine and Metabolic Surgery, Department of Surgery, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
lyden melanie
Melnitchouk, Nelya
Brigham and Women's Hospital, Dana Farber Cancer Center
Colorectal Poster Presentations 1
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nelya Melnitchouk
Melstrom, Laleh
City of Hope Medical Center
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Laleh Melstrom
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Laleh Melstrom
Melucci, Alexa
University of Rochester Medical Center
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Alexa Melucci
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Alexa Melucci
Menendez, Carolyn
Department of Surgery, Duke University
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Carolyn Menendez
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Carolyn Menendez
Meniawy, Tarek
15Sir Charles Gairdner Hospital
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Tarek Meniawy
Mensah, Boniface
Houston Methodist Hospital
P66: Medicaid Expansion Increases Early Lung Cancer Diagnosis in Urban Blacks
Location:SSO HUB: Rare/Metastatic Cancers Zone
Boniface Mensah
Merath, Katiuscha
Department of Surgery, University of Texas HSC San Antonio
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Katiuscha Merath
Merchant, Nipun
University of Miami Miller School of Medicine
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Nipun Merchant
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Nipun Merchant
Merchea, Amit
Mayo Clinic
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Amit Merchea
Merkow, Ryan
Northwestern University
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
Ryan Merkow
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Ryan Merkow
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Ryan Merkow
Merrill, Andrea
Boston Medical Center
Breast Poster Presentations 1
Location:SSO HUB: Breast & Endocrine Zone
Andrea Merrill
Mesirov, Jill
UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Jill Mesirov
Mesiti, Andrea
New York Presbyterian Weill Cornell Medical Center
P17: Trends in the Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Andrea Mesiti
Messina, Valentina
University Hospitals Birmingham NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Valentina Messina
Metcalfe, Kelly
Women's College Research Institute
6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada
Location:Veterans Memorial Auditorium
Kelly Metcalfe
Meterissian, Sarkis
MUHC Breast Centre, McGill University Medical School
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Sarkis Meterissian
Mettu, Niharika
Duke University Medical Center
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Niharika Mettu
Meyer, Inna
Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Inna Meyer
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Inna Meyer
Miceli, Rosalba
Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Rosalba Miceli
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Rosalba Miceli
Michels, Judith
Institut Gustave Roussy
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Judith Michels
Middleton, Mark
Churchill Hospital
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Mark Middleton
Milhem, Mohammed
Holden Comprehensive Cancer Center
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Mohammed Milhem
Minami, Christina
Brigham and Women's Hospital
Breast Poster Presentations 2
Location:SSO HUB: Breast & Endocrine Zone
Christina Minami
Mirza, Muhammad bilal
Department of surgery
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Muhammad bilal Mirza
Mitchell, John
University of Colorado School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
John Mitchell
Mitchell, Melissa
MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Melissa Mitchell
Mitchell, Owen
Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Owen Mitchell
Mittendorf, Elizabeth
Brigham and Womens Hospital/Harvard Medical School
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Elizabeth Mittendorf
Miura, John
University of Pennsylvania
Surgeons Role in Driving Window of Opportunity and Neoadjuvant Immunotherapy Trials
Location:SSO HUB: Immuno-Oncology Zone
John Miura
Moazzam, Zorays
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Zorays Moazzam
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Zorays Moazzam
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
Zorays Moazzam
Mogal, Harveshp
University of Washington
PSM Great Debate: HIPEC for Colorectal PM: Should it be Offered?
Location:Ballroom B
Harveshp Mogal
Mohr, Peter
Elbe Klinikum Buxtehude
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Peter Mohr
Mokhtari, Ali
Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Ali Mokhtari
Moldoveanu, Dan
Mayo Clinic Rochester
P4: Clinical Behavior, Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer by PR expression
Location:SSO HUB: Breast & Endocrine Zone
Dan Moldoveanu
Moncrieff, Marc
Norfolk & Norwich University Hospital
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Marc Moncrieff
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Marc Moncrieff
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Marc Moncrieff
Mongiu, Anne
Yale University
Treatment of Low Anterior Resection Syndrome
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Anne Mongiu
Monroe, Marcos
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Marcos Monroe
Moody, Alison
Ascension Medical Group
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Alison Moody
Moon, James
SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
James Moon
Moo, Tracy-Ann
Memorial Sloan Kettering Cancer Center
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tracy-Ann Moo
Moo-Young, Tricia
North Shore University Health System
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma
Location:Ballroom A
Tricia Moo-Young
MORIS, DIMITRIOS
Duke
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
DIMITRIOS MORIS
Mori, Taisuke
National Cancer Center Hospital
P24: Genome doubling shapes the evolution and prognosis of advanced head and neck cancer
Location:SSO HUB: Breast & Endocrine Zone
Taisuke Mori
Morosi, Carlo
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Carlo Morosi
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Carlo Morosi
Morris, Arden
Stanford University School of Medicine
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Arden Morris
Morris, David
St George Hospital
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
David Morris
Questions and Discussion
Location:Ballroom C
David Morris
Update on Bromac
Location:Ballroom C
David Morris
Morris, Montana
Yale University School of Medicine
20: Multi-omic Analysis Reveals Potential Mechanisms of EGFR-inhibitor Resistance in Right Sided Colon Cancer Liver Metastases
Location:Veterans Memorial Auditorium
Montana Morris
Morrow, Monica
Memorial Sloan Kettering Cancer Center
Building Your CV and Navigating Promotions
Location:Room 302
Monica Morrow
P1: Axillary dissection is avoidable in the majority of cT1N0 triple negative and HER2+ breast cancers having upfront surgery with adjuvant radiation
Location:SSO HUB: Breast & Endocrine Zone
Monica Morrow
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Monica Morrow
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Monica Morrow
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Monica Morrow
Morse, Michael
Duke University Medical Center
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Michael Morse
Mourne, Rebecca
TriHealth Cancer Institute
"Help the Doctor": How Best to Utilize APCs in Your Surgical Oncology Practice
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Rebecca Mourne
Movva, Sujana
Department of Medicine
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Sujana Movva
Mudd, Jacqueline
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Jacqueline Mudd
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Jacqueline Mudd
Mukherjee, Sumit
Albert Einstein College of Medicine
P14: ART1, a mono-ADP-ribosyl transferase, is increased by chemotherapy and radiotherapy and is a novel target in colorectal carcinoma.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sumit Mukherjee
Mukhtar, Rita
University of California San Francisco
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
Rita Mukhtar
Mulkerin, Daniel
University of Rochester Medical Center
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Daniel Mulkerin
Mullen, John
Massachusetts General Hospital and Harvard Medical School
Meet the Experts: Current Controversies in the Management of Gastric Cancer
Location:Room 304
John Mullen
Mullinax, John
H. Lee Moffitt Cancer Center
The Role of TIL Therapy in Sarcoma or Surgical Considerations for Tumor Tissue Procurement for TIL
Location:SSO HUB Theater
John Mullinax
Mungo, Benedetto
University of Colorado Anschutz Medical Campus
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Benedetto Mungo
Munir, Muhammad Musaab
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Muhammad Musaab Munir
Murimwa, Gilbert
UT Southwestern
49: Stroma Selective Inhibition of TGFβ – Genomic Stratification As The Key to Overcoming Failed Clinical Translation in Pancreatic Cancer
Location:Ballroom A
Gilbert Murimwa
Myers, Emily
University of Colorado
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Emily Myers
Myers, Sara
Memorial Sloan Kettering Cancer Center
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Sara Myers
Back to Top
